The Egyptian Society of Neurology, Psychiatry and Neurosurgery
Safety and efficacy of sodium oligomannate in patients with Alzheimer’s disease: a systematic review and meta-analysis
We aim to evaluate the efficacy and safety of a new marine oligosaccharide drug, sodium oligomannate (GV-971), developed in China to treat Alzheimer’s disease (AD).